Skimming through the transscript looking for an explanation for a very particular question..
MC: ".. We continue to solidify our institutional shareholders base and regain the confidence of Wall Street. .."
"..Our financial positions has significantly been enhanced through our receipt of $45 million with the UT collaboration agreement. Our $40 million public offering... And we ended 2018 with $72 million in cash.."
"..Some of the first ones to expect will be the achievement of our first milestone United Therapeutics. We anticipate this being completed, hopefully by the end of Q1.
We have multiple data publications coming out around Hypoglycemia safety and efficacy. We expect to complete pediatric cohort 2 and progress cohort 3. We expect Brazil
approval sometime during late Q1 or Q2.."
".. we continue to accelerate sales and will continue to make efforts that are in the best interest to shareholders.."
Mike, why did you give away 20% if the shares?
Given in how you got us there, it is bad to have the greatest amount of cash and not debt in the current situation!
Regardless what you said, that was NOT in the interest of the shareholders!
Still there is no explanation for it!
The 40 Million you got for it will be meaningless small very soon.. but any future shareholder value as you call it will only be 80%..